Your session is about to expire
← Back to Search
Quetiapine for Postpartum Depression
Study Summary
This trial is testing whether the drug quetiapine can help treat postpartum depression.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am able to understand and agree to the study's procedures.I am currently taking medication for my mood, depression, or sleep.I have been diagnosed with major depression or bipolar disorder related to childbirth.I cannot take quetiapine due to a physical illness, intolerance, or it didn't work for me.I am a woman aged between 18 and 45.I am currently undergoing psychotherapy.
- Group 1: Quetiapine
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What afflictions has Quetiapine been proven to alleviate?
"Quetiapine is a commonly prescribed medication for treating anxiety disorders, but its application extends to acute coryza, mental depression and even bipolar disorder."
What is the anticipated enrollment size for this investigation?
"Affirmative. The clinicaltrials.gov website illustrates that this study is presently recruiting patients, which were first advertised on March 18th 2022 and updated for the last time on the same date. A total of 30 participants are needed from a single medical facility."
Is Quetiapine a reliable and secure option for people?
"Quetiapine's safety rating is 1, as this Phase 1 trial has only yielded limited data regarding the drug's efficacy and security."
Can you provide a summary of the history and outcomes surrounding trials involving Quetiapine?
"Currently, there are 13 ongoing clinical tests of Quetiapine with 3 trials in their final stage. Most research is based around Bhubaneswar, Orissa but the drug is also being studied across 419 facilities."
What are the criteria for joining this clinical investigation?
"This clinical trial seeks 30 participants, aged 18-45 years old and diagnosed with depression. To be eligible for participation, potential patients must also have a DSM-5 diagnosis of Major Depressive Disorder (MDD) or Bipolar I & II; present scores >18 on the 17-item Hamilton Depression Rating Scale (HDRS), ≤12 Young Mania Rating Scale (YMRS); had delivery within 6 months prior to enrollment; and are outpatient women."
What are the fundamental goals of this medical trial?
"This 8-week trial seeks to measure the effects of glycated haemoglobin (HbA1c) tests. Secondary outcomes will be evaluated via three separate scales: Generalized Anxiety Disorder 7-item scale (with scores ranging from 0 to 21, with higher numbers indicating heightened anxiety), Edinburgh Postnatal Depression Scale (scores range from 0 to 30, where a score closer to 30 signifies greater depression symptoms,) and Young Mania Rating Scale which consists of four items given twice the weight as seven others graded on a 0 - 8 scale; this yields an aggregate total between 0 and 60, wherein 60 indicates poorer results."
Is enrollment open at this time for the trial?
"Evidenced by clinicaltrials.gov, this study is actively hunting for participants. This medical experiment was first made available on March 18th 2022 and has been revised since that date."
Does the trial recruitment process accept individuals of advanced age?
"The enrollment criteria for this study is adults aged between 18-45 years old. There are 196 trials targeting minors and 977 studies that involve seniors over 65."
Could you please explain if this is an innovative trial?
"Otsuka America Pharmaceutical first launched a clinical trial for Quetiapine in 2014, involving 200 participants. After this successful study, the drug was granted Phase 4 approval and currently there are 13 ongoing trials across 138 cities and 27 countries."
Share this study with friends
Copy Link
Messenger